Last $27.20 USD
Change Today +0.18 / 0.67%
Volume 195.6K
SGNT On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 2:40 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lorin Drake

Corporate Vice President of Sales, Sagent Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

61--

Background*

Mr. Lorin Drake has been Corporate Vice President of Sales of Sagent Pharmaceuticals, Inc., since August 2012. Mr. Drake served as Corporate Vice President of Sales and Marketing at Sagent Pharmaceuticals, Inc., since March 2012 until August 2012. Mr. Drake served as a Vice President of Sales and Marketing at Sagent Pharmaceuticals, Inc. from May 2006 to March 2012. Mr. Drake served as a Vice President of Sales of Fresenius Kabi Pharmaceuticals Holding, Inc. from March ...

Read Full Background

Corporate Headquarters*

1901 North Roselle Road
Schaumburg, Illinois 60195

United States

Phone: 847-908-1600
Fax: 847-908-1601

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Miami University
BS
Manchester College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $27.20 USD +0.18

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Aijaz Tobaccowalla Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee
Pfizer Limited
30.3M
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$621.0K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.